Global Financial Private Client, LLC Supernus Pharmaceuticals, Inc. Transaction History
Global Financial Private Client, LLC
- $267 Billion
- Q4 2024
A detailed history of Global Financial Private Client, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Global Financial Private Client, LLC holds 1 shares of SUPN stock, worth $38. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1Holding current value
$38% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SUPN
# of Institutions
281Shares Held
60.8MCall Options Held
27.7KPut Options Held
11.3K-
Black Rock Inc. New York, NY10.4MShares$398 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.13MShares$235 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.1MShares$195 Million2.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$110 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$101 Million0.09% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $2.05B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...